Bacteria from the genus Brucella are causative agents of brucellosis -a zoonotic disease which affects many wild and domestic animal species and humans. Taking into account the significant socio-economic and public health impact of brucellosis, its control is of great importance for endemic areas. The chosen control strategy could be successful only if adapted to the current epidemiological situation. This implies that a choice of appropriate diagnostic procedures for detection and typing of Brucella spp. strains are of essential importance. Significant advancement of molecular techniques and their advantages compared to classical methods, give strong arguments in promotion of these techniques as a powerful tool for comprehensive diagnostics of brucellosis. Considering this, the major tasks of the study were to select and implement molecular tests for detection and genotyping Brucella spp. and evaluate their performances using DNA from cultivated brucellae (islolates) and limited number of tissue samples from seropositive animals. The obtained results confirmed that implemented real time PCR for Brucella spp. detection, as well as MLVA-16 used for genotyping, have excellent analytical sensitivity (4.2 fg of Brucella DNA were successfully detected and genotyped). Furthermore, compared to bacteriological cultivation of Brucella spp., real time PCR and MLVA-16 protocols showed superior diagnostic sensitivity and detected Brucella DNA in tissues from which Brucella could not be cultivated. Based on the summarized study results, we propose a diagnostic algorithm for detection and genotyping of Brucella spp. bacteria. Routine use of proposed diagnostic algorithm will improve the effectiveness of infection confirmation and help for accurate evaluation of epidemiological situation. . canis, B. ovis, B. neotomae, B. pinnipedialis, B. ceti, B. Microti and B. inopinata. This classification of the genus Brucella is based on the differences in host preference, pathogenicity, phenotypic traits and genetic structure. However, it is very likely that novel species will be included in the genus soon, mainly as a result of advancement and increased use of molecular diagnostic tools (1). Infections in animals result in significant economic losses due to induced abortions, infertility, reduced milk and body weight production. Moreover, the presence of brucellosis in animals represents a constant risk for human infections, which are commonly characterized with fever, malaise, sweating and lymphadenopathy (2). In the absence of vaccine for human use, control of human brucellosis remains largely dependent on the control of the disease in animals (3).
INTRODUCTION
Bacteria from the genus Brucella are causative agents of brucellosis -a zoonotic disease which affects many wild and domestic animal species and humans. Currently, ten inopinata. This classification of the genus Brucella is based on the differences in host preference, pathogenicity, phenotypic traits and genetic structure. However, it is very likely that novel species will be included in the genus soon, mainly as a result of advancement and increased use of molecular diagnostic tools (1) . Infections in animals result in significant economic losses due to induced abortions, infertility, reduced milk and body weight production. Moreover, the presence of brucellosis in animals represents a constant risk for human infections, which are commonly characterized with fever, malaise, sweating and lymphadenopathy (2) . In the absence of vaccine for human use, control of human brucellosis remains largely dependent on the control of the disease in animals (3) .
Taking into account the significant socioeconomic and public health impact of brucellosis, its control is of great importance for endemic areas. Different scientifically approved approaches are available for brucellosis control. However, the chosen control strategy could be successful only if it is adapted to the current epidemiological situation, as well as to the economic and political situation in the country or the region (4, 5) . Epidemiology of brucellosis is very complex due to the possible involvement of different mammal (animal) and different Brucella species. This fact highlights the importance of the diagnostic procedures for detection and typing of Brucella, as powerful epidemiological tools which are indispensable for a successful control program.
The only unequivocal confi rmation of Brucella spp. infections is laboratory detection and identifi cation of the brucellae in the affected organism. Until recently, isolation of Brucella has been considered as a gold standard assay for brucellosis diagnosis (6, 7) . However, significant advancement of molecular techniques and their increased application in the diagnostic laboratories during the past two decades, has led to the formal recognition of these techniques as valid assays for defi nite diagnosis of brucellosis (8) . Unlike isolation, PCR based molecular tests do not require the presence of vital bacteria in the samples, provide quick and objective results and are safe and relatively easy to perform (7, 9) . Moreover, due to the possibility for detection of bacterial DNA even in the samples with small number of Brucellae, they have better sensitivity compared to isolation (6, 7, 10) . Numerous molecular assays using different targets for Brucella spp. identifi cation have been published in the last twenty fi ve years (11) (12) (13) (14) (15) (16) . Different methods are available for determination of species (17) (18) (19) (20) (21) , as well as for typing at subspecies level (22) (23) (24) (25) . Molecular typing based on the analysis of variable number of tandem repeats analysis (VNTRs) in multiple loci (MLVA), provides valuable epidemiological results and is of great value for investigating outbreaks. MLVA testing scheme consisting of 16 genetic loci (MLVA-16) has high discriminatory power at subspecies level and enable differentiation of unrelated Brucella spp. strains, which could not be differentiated by classical microbiological methods (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) . The existence of public database with MLVA-16 allelic profi les (http://mlva.u-psud.fr/ brucella/) allows comparison of the typed Brucella spp. strains at regional and international level (36) . In addition, allelic profiles could be used for species identification or confirmation, if necessary.
The purpose of this study was to establish and evaluate a diagnostic algorithm (fl owchart) for Brucella spp. detection and typing, which will exploit the advantages of fluorescence-detection based molecular techniques in terms of sensitivity, safety and testing time and hence provide improved brucellosis diagnostics when clinical samples are tested.
MATERIAL AND METHODS

Samples
One isolate of B. abortus (field strain MKD-1027), derived from culture collection of the Faculty of Veterinary Medicine-Skopje, and organs from 11 slaughtered seropositive ruminants (Table 3) were used for extraction of genomic DNA. Organs from one animal (spleen, supramammary, iliac and inguinal lymph nodes) were grinded and macerated together in a form of suspension suitable for cultivation, inoculated on selective (Farrell's) media and archived at -80°C as "tissue sample". Eleven tissue samples used in the study were randomly selected from the FVMS's collection of tissue samples kept at -80°C.
DNA extraction
Pure bacterial DNA used for implementation and optimization of the test protocols for detection and molecular typing was obtained from the MKD-1027 isolate using PureLink Genomic DNA kit (Life Technologies, USA), according to the manufacturer's instructions for Gram negative bacteria. Concentration and purity of extracted bacterial DNA was determined spectrophotometrically (A 260 and A 280 ) using NanoDrop 2000c (Thermo Scientifi c, USA). Total genomic DNA was extracted from tissue samples using the same commercial kit, according to the manufacturer's instructions for tissues. The genomic DNA extracted from tissue samples was used to evaluate the performance of implemented testing scheme.
Real time PCR
Genomic DNA from fi eld strain MKD-1027 was used for optimization and performance evaluation of implemented real time PCR for Brucella spp. detection. Primers and probe used in the test are targeting IS711 and are described elsewhere (11) . Eight tenfold dilutions corresponding to a DNA concentration range between 1.7 ng/μL and 0.17 fg/μL were prepared from the purified DNA sample and tested in duplicate. Real time PCR reaction was prepared in a final volume of 25 μL using 12.5 μL 2x RT PCR reaction mix for probes (Bio-Rad, USA), 8 μL nuclease-free water, 2 μL primer-probe mix and 2.5 μL of DNA sample. Final concentrations of primers and probe were 0.5 μM and 0.2 μM, respectively. Amplification was performed in IQ5 Thermal Cycler (Bio-Rad, USA) under the following conditions: initial denaturation at 95°C for 5 min and 42 cycles of denaturation at 95°C for 15 s, and combined annealing-extension at 60°C for 30 s. Efficacy of the reaction (E), coeffi cient of determination (R 2 ) and slope of the standard curve were calculated using IQ5 software. One of the DNA dilutions with high quantification cycle (Cq) value has been defined as a future "positive control sample" and was independently tested ten times. Obtained Cq values were used for calculation of coefficient of variation (CV) standing for interassay reproducibility and upper and lower limits of the positive control (95% and 99% confidence levels).
MLVA-16 genotyping
For achieving the best analytical sensitivity and repeatability of the capillary electrophoresis system used, all loci from the MLVA-16 panel (22, 24) were amplified in singleplex PCR reactions using 5' -fl uorescently (6-FAM) labeled forward primers and Taq PCR Master mix kit (Qiagen, USA). Depending on the amount of input DNA, three different protocols for PCR reaction set-up and cycling were used (Table 1) .
PCR reactions were set in a total volume of 15 μL (PCR-1 and PCR-2) and 25 μL (PCR-3), containing 1 x Qiagen master mix and 0.5 μM of each primer. All PCR amplifications were performed in a TC412 thermal cycler (Techne, UK). The size of the PCR products was determined using capillary electrophoresis on ABI 310 system (Applied Biosystems, USA). Briefly, undiluted (PCR-3) or diluted (PCR-1, PCR-2) products have been prepared for electro kinetic injection by adding deionized formamide (Applied Biosystems, USA) and GS LIZ500 or GS LIZ1200 (Applied Biosystems, USA) size standards. Amplified loci from referent B. abortus S19 and B. melitensis Rev-1 strains were used as a control strains. Fragment sizing was performed by GeneMapper software ver. 4.0, according to a generated standard curve. Obtained raw data for the size of each locus was recorded in an excel sheet. Measured fragment size was corrected for the previously determined measuring aberration of the instrument. Corrected values were converted in tandem repeat units using 
RESULTS
Real time PCR -culture dilutions
Bacterial DNA was detected in seven out of eight tenfold DNA dilutions when tested with the real time PCR assay for detection of Brucella spp., corresponding to analytical sensitivity of 4.2 fg bacterial DNA (Fig. 1, Table 2 ). The implemented test protocol amplified broad range of DNA concentrations (4.2 ng to 4.2 fg) with excellent linearity (R 2 = 0.997) and 85.5% reaction efficacy (Fig. 2) . 
MLVA-16 genotyping
The modified PCR protocol (PCR-3) used for amplification, combined with fluorescence based capillary electrophoresis system for detection, enabled detection of all loci from the MLVA-16 scheme, even in the highest real time PCR positive (Fig. 3) . Next dilution (10 -8 ) was negative, meaning that the lower limit of detection of the implemented MLVA-16 typing system was equal to the lower limit of detection observed in the implemented real time PCR for detection of Brucella spp. However, PCR-3 protocol should be used only for samples with minor DNA amounts (close to the lower limit of detection), which could not be genotyped using agar-gel electrophoresis. Otherwise, unspecific fragments are likely to appear (Fig. 4) , especially if DNA is extracted from clinical samples. The appearance of unspecific fragments could compromise the interpretation of results in situations when their size is very close to the size of existing alleles. (Table 3) . Brucella DNA was detected in seven tissues from which Brucella could not be cultivated, although (as expected) with higher Cq values. Finally, MLVA-16 profi les were successfully obtained for all samples. There were some reproducibility problems when sample with highest Cq value (1-AL) was testedsome of the loci required more than one attempt for obtaining visible signal. This could be explained with low amount of DNA in the 1-AL sample, which was very close to the lower limit of detection of the system.
DISCUSSION
Confi rmation of Brucella spp. infections is very important for successful control of brucellosis in animals. This is especially evident when the eradication programme is in its late stage and the prevalence of disease significantly decreased (4) . In this case, rapid confirmation of suspected infections and successful trace-back of its origin and routes, provide significant support to progress towards complete disease eradication. Hence, the selection of proper laboratory methods for rapid, sensitive and specific detection of Brucella spp., as well as Table 3 . Clinical samples in which Brucella DNA was detected by IS711 rt-PCR and MLVA-16 profi les were determined using the described protocols highly-discriminatory methods for its typing, play important role in the system of eradication.
As previously reported (11), real time PCR targeting IS711 segment of Brucella spp. is a highly sensitive assay and a good candidate for direct testing of clinical samples. In our study, analytical sensitivity of the IS711 real time PCR assay was 4.2 ng, which is comparable with findings of other authors (11, 37, 38) and proves the robustness of the implemented assay. Theoretically, if we take into account average genome sizes of Brucella members, IS711 real time PCR assay could detect only few bacterial cells. The excellent lower limit of detection is a result of application of real time PCR technology, as well as of the presence of more IS711 copies throughout the Brucella spp. genome.
Although the study was not designed to compare the performances of molecular detection and isolation, it confirmed the superior Brucella spp. detection capability of the IS711 real time PCR, compared to the isolation when different clinical samples were tested (Table 3) . Our results support the conclusion of other authors (39, 40) , that isolation itself is not sufficient for confirmation of infected animals during epidemiological investigations. Therefore, we have established a diagnostic flowchart for Brucella spp. detection/ identification based on real time PCR, in addition to isolation on selective media (Fig. 5) .
Whenever Brucella spp. is isolated, all molecular tests for species determination and subspecies typing usually perform well, because a high concentration of bacterial DNA is extracted from colonies. In other words, the analytical sensitivity of molecular methods is not an issue when Brucella spp. has been isolated from clinical samples. However, if Brucella spp. is not isolated, but is present in the clinical samples in small numbers which are detectable by the IS711 real time PCR, species and genotype of detected strain could be determined only if highly sensitive technologies are implemented.
The MLVA-16 typing system that we implemented had equal analytical sensitivity with the above mentioned real time PCR for Brucella spp. detection (Fig. 3) , meaning that MVLA-16 allelic profiles could be obtained for all detected Brucella spp. strains. This theoretical conclusion was practically evaluated with the successful genotyping of all clinical samples from Table 3 . Moreover, quantitative capabilities of the real time PCR technology provide precise quantization of Brucella DNA loads in the clinical samples, which is very important for selection of the most appropriate MLVA PCR protocol and successful genotyping. Taking into account that DNA sample obtained from the infected tissue contains huge amounts of host DNA, concentration of Brucella DNA could not be measured using the common spectrometric method.
As a summary of all results from the study, we established a diagnostic flowchart for molecular typing of Brucella spp. strains ( Figure 6 ) detected using the laboratory approach given in Figure 5 .
The described testing strategy enables highly sensitive Brucella spp. detection, and successful molecular characterization of detected strains. Its application could improve the effectiveness in infection confirmation and provide significant contribution in the accurate evaluation of epidemiological situations.
